| Literature DB >> 33589798 |
Bhavesh D Kevadiya1, Jatin Machhi1, Jonathan Herskovitz1,2, Maxim D Oleynikov1, Wilson R Blomberg1, Neha Bajwa3, Dhruvkumar Soni4, Srijanee Das1,2, Mahmudul Hasan4, Milankumar Patel1, Ahmed M Senan5, Santhi Gorantla1, JoEllyn McMillan1, Benson Edagwa1, Robert Eisenberg6, Channabasavaiah B Gurumurthy1, St Patrick M Reid2, Chamindie Punyadeera7, Linda Chang8,9, Howard E Gendelman10,11,12.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to nearly every corner of the globe, causing societal instability. The resultant coronavirus disease 2019 (COVID-19) leads to fever, sore throat, cough, chest and muscle pain, dyspnoea, confusion, anosmia, ageusia and headache. These can progress to life-threatening respiratory insufficiency, also affecting the heart, kidney, liver and nervous systems. The diagnosis of SARS-CoV-2 infection is often confused with that of influenza and seasonal upper respiratory tract viral infections. Due to available treatment strategies and required containments, rapid diagnosis is mandated. This Review brings clarity to the rapidly growing body of available and in-development diagnostic tests, including nanomaterial-based tools. It serves as a resource guide for scientists, physicians, students and the public at large.Entities:
Mesh：
Substances：
Year: 2021 PMID： 33589798 PMCID： PMC8264308 DOI： 10.1038/s41563-020-00906-z
Source DB: PubMed Journal: Nat Mater ISSN： 1476-1122 Impact factor: 47.656